Eredményeink a teljes jogú Eurotransplant-tagság óta. A Debreceni Vesetranszplantációs Központ tapasztalatai

Author:

Nemes Balázs1,Fedor Roland1,Kanyári Zsolt1,†Lőcsey Lajos1,Juhász Ferenc1,Kovács Dávid Ágoston1,Zádori Gergely1,Győry Ferenc1,P. Szabó Réka1,Zsom Lajos1,Szabó Tamás2,Illésy Lóránt1,Szabó-Pap Marcell1,Kincses Zsolt3,Szabó László4,Damjanovich László1,Balla József5,Asztalos László1

Affiliation:

1. Sebészeti Intézet, Szervtranszplantációs Nem Önálló Tanszék, Debreceni Egyetem, Általános Orvostudományi Kar Debrecen, Móricz Zs. krt. 22., 4032

2. Gyermekgyógyászati Intézet, Gyermek Belgyógyászati Nem Önálló Tanszék, Debreceni Egyetem, Általános Orvostudományi Kar Debrecen

3. Általános Sebészeti Osztály, Kenézy Gyula Kórház és Rendelőintézet Debrecen

4. Cardiff Transplant Unit, University Hospital of Wales Cardiff, United Kingdom

5. Belgyógyászati Intézet, Nefrológiai Tanszék, Debreceni Egyetem, Általános Orvostudományi Kar Debrecen

Abstract

Introduction: The first renal transplantation was completed in 1991 at the University of Debrecen. In 2013 Hungary joined Eurotransplant. Aim: The authors retrospectively compared the trends. Method: Comparison between Period A (from January 1, 2008 to August 31, 2013) and Period B (from September 1, 2013 to October 22, 2015). Results: The proportion of living transplants rose from 3.5% to 9.1 %. During period B over 25% of utilized donors were over 60 years of age. Recipients with body mass index above 30 kg/m2 increased from 12% to 31%. Prevalence of diabetes among recipients rose twofold. Uretero-neocystostomy was used during period A (99%) while in period B end to side uretero-ureteral anastomosis has also gained popularity (68%). In 2013 the authors introduced routine use of induction treatment. Acute rejection rate decreased from 34% to 8%. The rate of surgical complications did not change. Acute bacterial infections decreased from 41% to 33%. Cumulative renal allograft 1, 3 and 5 year survival rates were 86.6%, 85% and 82.7% in group A vs. projected rates 88%, 84% and 84% in group B, respectively. Conclusions: Despite the growing proportion of expanded criteria donors, the authors were able to maintain a low incidence of delayed graft function and a favorable graft survival. Since 2013 the authors introduced treatments for acute humoral rejection according to international standards. Orv. Hetil., 2016, 157(24), 925–937.

Publisher

Akademiai Kiado Zrt.

Subject

General Medicine

Cited by 14 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3